 Ms. Meynadier has more than 20 years of experience in medical technology operations and leadership and most recently served as Chief Executive Officer of EOS Imaging. Together with the Companys recently announced partnership with Exact Imaging, I believe EDAPs end-to-end Focal One solution represents a significant advancement in the treatment and ablation of not only prostate tissue, but other soft tissue indications as well. 